David A. Davis

University of Miami — United States

Immunology and Microbiology · Life Sciences

50h-index12.6kcitations255works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(63), HIV/AIDS drug development and treatment(34), Viral-associated cancers and disorders(32), Innovations in Medical Education(30), Immune Cell Function and Interaction(25)

Publications253 total

Abstract WP344: Inflammatory and Epigenetic Changes in the Human Ischemic Stroke Brain – Novel Insights for Therapeutic Targets
Stroke·2026
Glucose Extremes and Cognitive Function: A Review of the Neurological Impacts of Hypoglycemia and Hyperglycemia in Type 1 Diabetes
Diabetes Spectrum·2025Open Access
Caspase cleavage of Kaposi sarcoma-associated herpesvirus proteins: a role for K5 in preventing caspase-mediated cell death during lytic replication
Journal of Virology·2025Open Access
Evaluating the impact of reusable gowns on postoperative infection rates in hand surgery
Surgery in Practice and Science·2025Open Access
Novel Cereblon‐Binding Immunomodulators Have Increased Potency Against Gammaherpesvirus‐ Associated Lymphomas In Vitro
Journal of Medical Virology·2025· 1 citedOpen Access
A Transcriptomic Roadmap of Parkinson’s Disease Progression at Single Cell Resolution
2025· 1 citedOpen Access
Caspase Cleavage of Kaposi Sarcoma-Associated Herpesvirus Proteins: A role for K5 in Preventing Caspase-Mediated Cell Death during Lytic Replication
2025Open Access
The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region
PLoS Pathogens·2025Open Access
The Elevated Expression of ORF75, a Lytic KSHV Gene, in Kaposi Sarcoma Lesions is Driven by a GC-rich DNA cis Element in its Promoter Region
2024Open Access
Targeting hypoxia-inducible factors in malignancies caused by Kaposi’s sarcoma associated herpesvirus
Global Health & Medicine·2024Open Access
Author response for "Discovery of a Nasal Spray Steroid, Tixocortol, as an Inhibitor of SARS-CoV-2 Main Protease and Viral Replication"
2024
The NeuroBioBank Whole-Genome Catalog: Sequencing from human brain donors with central nervous system disorders
2024Open Access
Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases
Blood·2024· 17 citedOpen Access
Gurney’s Homefolks
Appalachian Journal·2024
Discovery of a nasal spray steroid, tixocortol, as an inhibitor of SARS-CoV-2 main protease and viral replication
RSC Medicinal Chemistry·2024· 3 citedOpen Access
Hypoxia and hypoxia‐inducible factors in Kaposi sarcoma‐associated herpesvirus infection and disease pathogenesis
Journal of Medical Virology·2023· 12 citedOpen Access
Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas
Scientific Reports·2023· 3 citedOpen Access
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants
Science Advances·2023· 6 citedOpen Access
Abstract PL02-04: Malignancies in People with HIV: Successes and Challenges at the Intersection of Virology, Immunology, and Oncology
Cancer Research·2023
Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease
OncoImmunology·2023· 11 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Robert Yarchoan(16), Henry M. Fales(5), Debananda Das(5), Arun K. Ghosh(5), Hiroaki Mitsuya(5), Paul E. Mazmanian(4), Jonathan L. Heeney(4), Haydar Bulut(4), Fonda M. Newcomb(4), Victoria Wang(3), Muzammel Haque(3), Giovanna Tosato(3), Joanna E. Burdette(3), Hironori Hayashi(3), Yuki Takamatsu(3), Nobutoki Takamune(3), Shogo Misumi(3), Willy Bogers(3), Paul T. Wingfield(3), Stephen J. Stahl(3)